Quantitative Systematic Strategies’s Regeneron Pharmaceuticals REGN Stock Holding History

Quantitative Systematic Strategies’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-931	Closed	-$581K	–	693
2020 Q2	$581K	Buy	+931	New	+$528K	0.11%	274
2019 Q2	–	Sell	-491	Closed	-$202K	–	552
2019 Q1	$202K	Buy	+491	New	+$202K	0.05%	329
2015 Q4	–	Sell	-1,631	Closed	-$757K	–	925
2015 Q3	$757K	Buy	1,631 +1,071	+191%	+$575K	0.37%	84
2015 Q2	$283K	Buy	+560	New	+$273K	0.06%	423
2015 Q1	–	Sell	-525	Closed	-$215K	–	480
2014 Q4	$215K	Buy	+525	New	+$206K	0.09%	270
2014 Q3	–	Sell	-826	Closed	-$233K	–	373
2014 Q2	$233K	Buy	+826	New	+$245K	0.17%	213

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantitative Systematic Strategies's REGN Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Regeneron Pharmaceuticals (REGN) in Q3 2020, closing a stake of 931 shares — an estimated $581K sold.

Quantitative Systematic Strategies first reported a position in REGN in Q2 2014 and held it in 6 quarters. The position peaked at $757K in Q3 2015. 907 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

Quantitative Systematic Strategies reported no remaining Regeneron Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 931 Regeneron Pharmaceuticals shares in Q3 2020, an estimated $581K.
Quantitative Systematic Strategies first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 6 quarters.
Quantitative Systematic Strategies's Regeneron Pharmaceuticals position peaked at $757K in Q3 2015.
907 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.